DeMMO: Longitudinal and Cross-Disease Modelling of Digital Mobility Outcomes via Multi-Task Learning
DeMMO is an interpretable multi-task learning framework for longitudinal, multi-disease, and multi-outcome modelling of digital mobility outcomes (DMOs) from wearable sensors It introduces an automatic cross-disease and cross-outcome relation-learning mechanism that discovers signed relationships directly from longitudinal coefficient matrices, enabling selective information sharing even when disease cohorts have no overlapping participants The framework combines temporal regularization with sta
Analysis
TL;DR
- DeMMO is an interpretable multi-task learning framework for longitudinal, multi-disease, and multi-outcome modelling of digital mobility outcomes (DMOs) from wearable sensors
- It introduces an automatic cross-disease and cross-outcome relation-learning mechanism that discovers signed relationships directly from longitudinal coefficient matrices, enabling selective information sharing even when disease cohorts have no overlapping participants
- The framework combines temporal regularization with stable and visit-specific feature selection to model how multivariate DMO-clinical outcome relationships evolve jointly across diseases
- Evaluated on the large-scale Mobilise-D dataset with 24 harmonized DMOs across five visits and multiple mobility-limiting conditions, DeMMO outperforms nine strong linear, longitudinal, and deep-regression baselines
- Stability selection identifies reliable longitudinal DMO patterns with potential for clinical validation and disease monitoring
Why It Matters
This work addresses a critical gap in digital health research: most wearable-based studies analyze a single disease at a single timepoint, missing the opportunity to understand how mobility biomarkers relate to clinical outcomes across diseases and over time. For AI practitioners working in healthcare and time-series modeling, DeMMO demonstrates how multi-task learning with structured regularization can enable knowledge transfer across disjoint cohorts—a common real-world constraint in clinical data. The interpretable nature of the framework also aligns with the growing demand for explainable AI in medical applications.
Technical Details
- Longitudinal DMO coefficient matrix: Each disease-outcome objective is represented by a coefficient matrix capturing the relationship between wearable-derived mobility features and clinical outcomes across visits, enabling explicit modeling of temporal evolution
- Cross-disease/cross-outcome relation learning: The core innovation is an automatic mechanism that learns signed (positive/negative) relations directly from longitudinal mappings, allowing selective information sharing between diseases and outcomes without requiring paired participants across cohorts
- Temporal regularization + feature selection: DeMMO combines temporal smoothness constraints with stable (shared across visits) and visit-specific feature selection, balancing consistency and adaptability in longitudinal patterns
- Evaluation on Mobilise-D: Tested on a multicentre dataset with 24 harmonized real-world DMOs over five visits across multiple mobility-limiting conditions, compared against nine baselines spanning linear models, longitudinal methods, and deep regression architectures
- Interpretability via stability selection: The framework produces clinically interpretable longitudinal DMO patterns ranked by selection stability, supporting downstream validation and monitoring use cases
Industry Insight
- The ability to learn cross-disease relationships from disjoint cohorts is highly relevant to real-world healthcare AI, where patient-level data sharing across studies is often restricted by privacy regulations—this approach could accelerate biomarker discovery without requiring centralized data pooling
- As wearable sensor adoption grows in clinical trials and remote patient monitoring, frameworks like DeMMO that can jointly model multiple outcomes across conditions will become increasingly valuable for building comprehensive digital phenotyping pipelines
- The emphasis on interpretability through stability selection reflects a broader industry shift toward clinically deployable AI; practitioners should consider how model transparency and feature-level insights can facilitate regulatory approval and clinician adoption in digital health applications
Disclaimer: The above content is generated by AI and is for reference only.